Heterochromatin loosening by the Oct4 linker region facilitates Klf4 binding and iPSC reprogramming.
Keshi ChenQi LongGuangsuo XingTianyu WangYi WuLinpeng LiJuntao QiYanshuang ZhouBochao MaHans R SchölerJinfu NieDuan-Qing PeiXingguo LiuPublished in: The EMBO journal (2019)
The success of Yamanaka factor reprogramming of somatic cells into induced pluripotent stem cells suggests that some factor(s) must remodel the nuclei from a condensed state to a relaxed state. How factor-dependent chromatin opening occurs remains unclear. Using FRAP and ATAC-seq, we found that Oct4 acts as a pioneer factor that loosens heterochromatin and facilitates the binding of Klf4 and the expression of epithelial genes in early reprogramming, leading to enhanced mesenchymal-to-epithelial transition. A mutation in the Oct4 linker, L80A, which shows impaired interaction with the BAF complex component Brg1, is inactive in heterochromatin loosening. Oct4-L80A also blocks the binding of Klf4 and retards MET. Finally, vitamin C or Gadd45a could rescue the reprogramming deficiency of Oct4-L80A by enhancing chromatin opening and Klf4 binding. These studies reveal a cooperation between Oct4 and Klf4 at the chromatin level that facilitates MET at the cellular level and shed light into the research of multiple factors in cell fate determination.
Keyphrases
- transcription factor
- optical coherence tomography
- genome wide
- diabetic retinopathy
- dna binding
- induced pluripotent stem cells
- gene expression
- dna damage
- optic nerve
- binding protein
- cell fate
- stem cells
- dna methylation
- induced apoptosis
- poor prognosis
- single cell
- tyrosine kinase
- genome wide identification
- cell proliferation
- rna seq
- long non coding rna
- cell death
- smoking cessation
- simultaneous determination